Recombinant Peglated human erythropoietin（Angde ）
重组聚乙二醇化人促红素注射液（昂德生物）
Report date: 2022/03/14 20:00:35
Base Information
Drug NameRecombinant Peglated human erythropoietin（Angde ）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChina Resources Angde Biotech Pharma Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChina Resources Angde Biotech Pharma Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A